CD36 expression has been reported in cancer cell lines from different intrinsic subtypes: luminal (Liang et al., 2018; Gyamfi et al., 2021); basal (Castelli et al., 2021; Gyamfi et al., 2021) and HER2-enriched (Feng et al., 2020), but further studies are required to analyze its functional role in those subtypes. The gene discussed is CD36; the disease is cancer.